High-intensity Focused Ultrasound (HIFU) Articles

Although radiotherapy to the prostate for cancer is effective, recurrence occurs in 10-15% within 5 years. Traditional salvage treatments for men with radiorecurrent prostate cancer comprise of watchful waiting (WW) with or without androgen deprivation therapy (ADT) or radical prostatectomy (RP).

BERKELEY, CA (UroToday.com) - More patients with localized prostate cancer elect to undergo active surveillance (AS) in order to postpone active treatment until disease progression.

BERKELEY, CA (UroToday.com) - In our recently published article, we presented an up-to-date review of the available literature on high-intensity focused ultrasound (HIFU) as a definitive treatment of prostate cancer.

Over the past 25 years, the average life expectancy for men has increased almost 4 years, and the age of prostate cancer detection has decreased an average of 10 years with diagnosis increasingly made at early-stage disease where curative therapy is possible.

BERKELEY, CA (UroToday.com) - We have recently published an article on our experience with hemi-ablation high-intensity focused ultrasound to treat unilateral localised prostate cancer.

To report the oncological and functional outcomes of salvage hemiablation high-intensity focused ultrasound (HIFU) in patients with unilateral radio-recurrent prostate cancer.

Patients with biochemical recurrence (BCR) after primary radiation therapy and evidence of unilateral organ confined recurrence based on a complete match between mpMRI and MRI targeted biopsies were included.

BERKELEY, CA (UroToday.com) - In 2012, 241 740 men were diagnosed with prostate cancer -- currently the most commonly diagnosed malignancy in men -- accounting for 29% of all male cancers and 9% of male cancer deaths.

Patients with localized prostate cancer (PCa) are often treated with radical prostatectomy (RP). However, more than 30% of such patients have high risk of recurrence. Salvage radiotherapy (SRT), androgen deprivation therapy (ADT) and combination of radiotherapy and ADT are the standard care for recurrent PCa.